The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(5-(4-carbamimidoylphenyl)furan-2-yl)-2-naphthimidamide ID: ALA1650568
PubChem CID: 53320552
Max Phase: Preclinical
Molecular Formula: C22H18N4O
Molecular Weight: 354.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: DB1173 | CHEMBL1650568|DB1173
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3ccc4ccc(C(=N)N)cc4c3)o2)cc1
Standard InChI: InChI=1S/C22H18N4O/c23-21(24)15-5-3-14(4-6-15)19-9-10-20(27-19)16-7-1-13-2-8-17(22(25)26)12-18(13)11-16/h1-12H,(H3,23,24)(H3,25,26)
Standard InChI Key: KEWJKDDWQUBRDE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-3.4625 -2.7310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4638 -3.5599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7497 -3.9734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0294 -3.5593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0325 -2.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7517 -2.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1799 -3.9720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8948 -3.5578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1811 -4.7982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3194 -2.3110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6504 -2.7984 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0196 -2.3150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2331 -1.5284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0593 -1.5258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7298 -2.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7257 -3.5483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1462 -2.7254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4363 -2.3177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1475 -3.5504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4350 -3.9584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4331 -4.7778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1431 -5.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8564 -4.7768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8547 -3.9589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1426 -6.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4269 -6.4289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8579 -6.4297 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
13 14 1 0
14 10 2 0
2 7 1 0
12 15 1 0
3 4 2 0
15 16 2 0
16 20 1 0
7 8 2 0
19 17 1 0
17 18 2 0
18 15 1 0
7 9 1 0
4 5 1 0
19 20 2 0
5 10 1 0
20 21 1 0
10 11 1 0
21 22 2 0
2 3 1 0
22 23 1 0
5 6 2 0
23 24 2 0
24 19 1 0
6 1 1 0
22 25 1 0
1 2 2 0
25 26 1 0
11 12 1 0
25 27 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.41Molecular Weight (Monoisotopic): 354.1481AlogP: 4.33#Rotatable Bonds: 4Polar Surface Area: 112.88Molecular Species: BASEHBA: 3HBD: 4#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.52CX LogP: 3.08CX LogD: -1.72Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.32Np Likeness Score: -0.05
References 1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R.. (2009) In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model., 53 (12): [PMID:19786604 ] [10.1128/aac.00422-09 ]